Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
The etiology of ring lesions on diffusion-weighted imaging.
Aquatic training in MS: neurotherapeutic impact upon quality of life.
Leuprolide Acetate, a GnRH Agonist, Improves Experimental Autoimmune Encephalomyelitis: A Possible Therapy for Multiple Sclerosis.
The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.
Disease mechanisms in MS: RNA profiling uncovers two distinct subsets of patients with multiple sclerosis.
Pathology of multiple sclerosis: where do we stand?
Spinal cord imaging in multiple sclerosis: Filling the gap with the brain.
Five years follow-up study and failures analysis of Botulinum toxin repeated injections to treat neurogenic detrusor overactivity.
Mirna-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.
Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients.
Small and Long Regulatory RNAs in the Immune System and Immune Diseases.
Body fluid biomarkers for multiple sclerosis-the long road to clinical application.
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
[Understanding needs of people with Multiple Sclerosis. Perspective of patients and significant others in the German-speaking part of Switzerland].
Role of early viral infections in development of multiple sclerosis.
Multiple sclerosis presenting initially with a worsening of migraine symptoms.
From genes to characteristics of multiple sclerosis.
Severe Bilateral Heterotopic Ossification in a Patient With Multiple Sclerosis.
OPtimizing CNS drug development using molecular imaging.
2014 multiple sclerosis therapeutic update.
Estimating typical multiple sclerosis disability progression speed from clinical observations.
Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial.
Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy.
Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
267
268
269
270
271
272
273
274
275
…
next ›
last »